Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1990 May;63(5):291–294. doi: 10.1136/hrt.63.5.291

Streptokinase treatment for femoral artery thrombosis after arterial cardiac catheterisation in infants and children.

F Brus 1, M Witsenburg 1, W J Hofhuis 1, J A Hazelzet 1, J Hess 1
PMCID: PMC1024479  PMID: 2278799

Abstract

Data on 205 children who underwent retrograde arterial catheterisation were studied to assess the frequency of femoral artery thrombosis and the safety and efficacy of systemic streptokinase treatment for this complication. In 29 (14%) a transarterial balloon dilatation was performed. In 15 (7.3%) patients impaired arterial perfusion due to vascular spasm with or without thrombus formation was seen in the cannulated leg after catheterisation. Despite heparinisation, signs of impaired arterial circulation persisted in nine patients (4.4% of the total). In these patients femoral artery thrombosis was strongly suspected. Six (53%) of these had undergone a balloon dilatation. Therefore in this study the risk of femoral artery thrombosis developing was 12 times greater after transarterial balloon dilatation than after arterial catheterisation without dilatation (20.6% v 1.7%). Systemic infusion of streptokinase was started in all patients with femoral artery thrombosis. Arterial perfusion became normal in all patients, though in one this was delayed. Haematological monitoring showed lengthening of the thrombin time and a decrease of the fibrinogen concentration during streptokinase treatment. There were no serious complications. Systemic infusion of streptokinase is a safe and useful treatment in children with persistent femoral artery thrombosis after arterial cardiac catheterisation.

Full text

PDF
291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Delaplane D., Scott J. P., Riggs T. W., Silverman B. L., Hunt C. E. Urokinase therapy for a catheter-related right atrial thrombus. J Pediatr. 1982 Jan;100(1):149–152. doi: 10.1016/s0022-3476(82)80258-8. [DOI] [PubMed] [Google Scholar]
  2. Ekelund H., Hedner U., Nilsson I. M. Fibrinolysis in newborns. Acta Paediatr Scand. 1970 Jan;59(1):33–43. doi: 10.1111/j.1651-2227.1970.tb15511.x. [DOI] [PubMed] [Google Scholar]
  3. Eskridge J. M., Becker G. J., Rabe F. E., Richmond B. D., Holden R. W., Yune H. Y., Klatte E. C. Catheter-related thrombosis and fibrinolytic therapy. Radiology. 1983 Nov;149(2):429–432. doi: 10.1148/radiology.149.2.6622686. [DOI] [PubMed] [Google Scholar]
  4. Estelles A., Aznar J., Gilabert J., Parrilla J. J. Dysfunctional plasminogen in full-term newborn. Pediatr Res. 1980 Nov;14(11):1180–1185. doi: 10.1203/00006450-198011000-00006. [DOI] [PubMed] [Google Scholar]
  5. Freed M. D., Keane J. F., Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation. 1974 Sep;50(3):565–569. doi: 10.1161/01.cir.50.3.565. [DOI] [PubMed] [Google Scholar]
  6. Girod D. A., Hurwitz R. A., Caldwell R. L. Heparinization for prevention of thrombosis following pediatric percutaneous arterial catheterization. Pediatr Cardiol. 1982;3(2):175–180. doi: 10.1007/BF02312966. [DOI] [PubMed] [Google Scholar]
  7. Hess J., Mooyaart E. L., Busch H. J., Bergstra A., Landsman M. L. Percutaneous transluminal balloon angioplasty in restenosis of coarctation of the aorta. Br Heart J. 1986 May;55(5):459–461. doi: 10.1136/hrt.55.5.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ino T., Benson L. N., Freedom R. M., Barker G. A., Aipursky A., Rowe R. D. Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. Am Heart J. 1988 Mar;115(3):633–639. doi: 10.1016/0002-8703(88)90815-0. [DOI] [PubMed] [Google Scholar]
  9. Kan J. S., White R. I., Jr, Mitchell S. E., Gardner T. J. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary-valve stenosis. N Engl J Med. 1982 Aug 26;307(9):540–542. doi: 10.1056/NEJM198208263070907. [DOI] [PubMed] [Google Scholar]
  10. Mansfield P. B., Gazzaniga A. B., Litwin S. B. Management of arterial injuries related to cardiac catheterization in children and young adults. Circulation. 1970 Sep;42(3):501–507. doi: 10.1161/01.cir.42.3.501. [DOI] [PubMed] [Google Scholar]
  11. Marder V. J., Sherry S. Thrombolytic therapy: current status (1). N Engl J Med. 1988 Jun 9;318(23):1512–1520. doi: 10.1056/NEJM198806093182306. [DOI] [PubMed] [Google Scholar]
  12. Marder V. J., Sherry S. Thrombolytic therapy: current status (2). N Engl J Med. 1988 Jun 16;318(24):1585–1595. doi: 10.1056/NEJM198806163182406. [DOI] [PubMed] [Google Scholar]
  13. Stanger P., Heymann M. A., Tarnoff H., Hoffman J. I., Rudolph A. M. Complications of cardiac catheterization of neonates, infants, and children. A three-year study. Circulation. 1974 Sep;50(3):595–608. doi: 10.1161/01.cir.50.3.595. [DOI] [PubMed] [Google Scholar]
  14. Wessel D. L., Keane J. F., Fellows K. E., Robichaud H., Lock J. E. Fibrinolytic therapy for femoral arterial thrombosis after cardiac catheterization in infants and children. Am J Cardiol. 1986 Aug 1;58(3):347–351. doi: 10.1016/0002-9149(86)90075-5. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES